Switzerland-based biotech VC fund advised by Bellevue Asset Management, investing exclusively in private innovative drug development companies.

Schwyz, Switzerland · 4+ investments · 4 portfolio companies

Growth
Late Stage
Seed
Early Stage
Biotech
Drug Development
pharmaceuticals
Life Sciences
Headquarters
Schwyz, Switzerland
Founded
2018
AUM
$205.0M
Portfolio Companies
4
Total Investments
4
Last Investment
Jun 2026
Geographic Focus
Europe, United States, Switzerland

Investment Thesis

Invest exclusively in private innovative drug development companies with emphasis on novel medicines for severe diseases; advised by Bellevue Asset Management.

BB Pureos is a Venture Capital firm based in Schwyz, Switzerland. It has made 4 investments in Biotech and Drug Development, including AnaCardio, Acrivon Therapeutics and Tavo Biotherapeutics.

Portfolio4

Co-investors16

Sign up to view co-investors

16 co-investors across 17 shared portfolio companies — who they back alongside, and how often they lead.

Venture Capital ×10 · Hedge Fund ×2 · Other ×2 · 11 shared rounds

Investment History

Sign up to view investment history

Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.

Your firm? Embed this profile

Add the live badge to your site — it stays current as your portfolio data updates.

BB Pureos on Indexed.vc
<a href="https://indexed.vc/investors/bb-pureos"><img src="https://indexed.vc/api/badge/investor/bb-pureos" alt="BB Pureos on Indexed.vc" width="260" height="76" /></a>